{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:04:20Z","timestamp":1772881460462,"version":"3.50.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Advances in the diagnosis and treatment of inherited bone marrow failure syndromes (IBMFS) have provided insight into the complexity of these diseases. The diseases are heterogeneous and characterized by developmental abnormalities, progressive marrow failure, and predisposition to cancer. A correct diagnosis allows for appropriate treatment, genetic counseling, and cancer surveillance. The common IBMFSs are Fanconi anemia, dyskeratosis congenita, and Diamond-Blackfan anemia. Hematopoietic cell transplantation (HCT) offers curative treatment of the hematologic complications of IBMFS. Because of the systemic nature of these diseases, transplant strategies are modified to decrease immediate and late toxicities. HCT from HLA-matched related or unrelated donors offers excellent survival for young patients in aplasia. Challenges include the treatment of adults with marrow aplasia, presentation with myeloid malignancy regardless of age, and early detection or treatment of cancer. In this article, I will describe our approach and evaluation of patients transplanted with IBMFS and review most frequent complications before and after transplant.<\/jats:p>","DOI":"10.1182\/hematology.2020000095","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T02:57:57Z","timestamp":1607137077000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes"],"prefix":"10.1182","volume":"2020","author":[{"given":"Carmem","family":"Bonfim","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation, General Hospital of the Federal University of Parana, Curitiba, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2021010115051374000_B1","first-page":"2257","article-title":"Inherited bone marrow failure syndromes: considerations pre- and posttransplant","volume-title":"Blanche P Alter Blood","author":"Alter","year":"2017"},{"issue":"1","key":"2021010115051374000_B2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/hematology.2019000021","article-title":"Genetic predisposition to MDS: diagnosis and management","volume":"2019","author":"Furutani","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2021010115051374000_B3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/hematology.2019000020","article-title":"Monitoring and treatment of MDS in genetically susceptible persons","volume":"2019","author":"Davies","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"2021010115051374000_B4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"7","key":"2021010115051374000_B5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2016.03.007","article-title":"Long-term survival, organ function, and malignancy after hematopoietic stem cell transplantation for Fanconi anemia","volume":"22","author":"Bonfim","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2021010115051374000_B6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bjh.14615","article-title":"How I manage patients with Fanconi anaemia","volume":"178","author":"Dufour","year":"2017","journal-title":"Br J Haematol"},{"issue":"9","key":"2021010115051374000_B7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2015.117","article-title":"Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"50","author":"Peffault de Latour","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"2021010115051374000_B8","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","article-title":"Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience","volume":"122","author":"Peffault de Latour","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2021010115051374000_B9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2021010115051374000_B10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17474086.2016.1268048","article-title":"Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations","volume":"10","author":"Ebens","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"16","key":"2021010115051374000_B11","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2016-09-743112","article-title":"Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study","volume":"129","author":"Mehta","year":"2017","journal-title":"Blood"},{"issue":"12","key":"2021010115051374000_B12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2007.08.004","article-title":"HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg\/kg of cyclophosphamide","volume":"13","author":"Bonfim","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2021010115051374000_B13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbmt.2008.06.020","article-title":"HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens","volume":"14","author":"Pasquini","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021010115051374000_B14","first-page":"270","article-title":"Excellent outcome for 91 Fanconi anemia patients undergoing matched related transplantation using cyclophosphamide 60mg\/kg in Curitiba, Brazil. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions","volume":"53","author":"Bonfim","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2021010115051374000_B15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2017.05.022","article-title":"Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on late effects after pediatric HCT","volume":"23","author":"Dietz","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021010115051374000_B16","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1182\/blood.V128.22.5075.5075","article-title":"Excellent treatment of bone marrow failure for patients with Fanconi anemia without matched related donors","volume":"128","author":"Ribeiro","year":"2016","journal-title":"Blood"},{"key":"2021010115051374000_B17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/asheducation-2017.1.96","article-title":"Treatment of inherited bone marrow failure syndromes beyond transplantation","volume":"2017","author":"Calado","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"2021010115051374000_B18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/08880018.2015.1129567","article-title":"Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany","volume":"33","author":"Paustian","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"issue":"7","key":"2021010115051374000_B19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.24373","article-title":"Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology)","volume":"91","author":"Svahn","year":"2016","journal-title":"Am J Hematol"},{"issue":"2","key":"2021010115051374000_B20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbmt.2016.11.006","article-title":"Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with Fanconi anemia","volume":"23","author":"Bonfim","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2021010115051374000_B21","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.bbmt.2019.07.010","article-title":"Successful outcome in patients with fanconi anemia undergoing T cell-replete mismatched related donor hematopoietic cell transplantation using reduced-dose cyclophosphamide post-transplantation","volume":"25","author":"Ayas","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021010115051374000_B22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/sci.2019.10.04","article-title":"Cord blood transplantation for bone marrow failure syndromes: state of art","volume":"6","author":"Pagliuca","year":"2019","journal-title":"Stem Cell Investig"},{"issue":"3","key":"2021010115051374000_B23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.rbmo.2014.05.010","article-title":"Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching","volume":"29","author":"Kahraman","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"2021010115051374000_B24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.15006","article-title":"Transplant results in adults with Fanconi anaemia","volume":"180","author":"Bierings","year":"2018","journal-title":"Br J Haematol"},{"issue":"24","key":"2021010115051374000_B25","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2021010115051374000_B26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.25810","article-title":"Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: a retrospective analysis on behalf of EBMT group","volume":"95","author":"Giardino","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"2021010115051374000_B27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jc.2014-4357","article-title":"Endocrine disorders in Fanconi anemia: recommendations for screening and treatment","volume":"100","author":"Petryk","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021010115051374000_B28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cncy.22249","article-title":"Diagnostic accuracy of brush biopsy\u2013based cytology for the early detection of oral cancer and precursors in Fanconi anemia","volume":"128","author":"Velleuer","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"2021010115051374000_B29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbmt.2014.10.009","article-title":"Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia","volume":"21","author":"Grein Cavalcanti","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2021010115051374000_B30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10456-018-9640-7","article-title":"Understanding the evolving phenotype of vascular complications in telomere biology disorders","volume":"22","author":"Higgs","year":"2019","journal-title":"Angiogenesis"},{"issue":"20","key":"2021010115051374000_B31","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"2021010115051374000_B32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.15495","article-title":"Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita","volume":"183","author":"Fioredda","year":"2018","journal-title":"Br J Haematol"},{"issue":"8","key":"2021010115051374000_B33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021010115051374000_B34","first-page":"364","article-title":"Hematopoietic cell transplantation for dyskeratosis congenita: experience in 28 patients. The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians\u2013Poster Session","volume":"54","author":"Nichele","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2021010115051374000_B35","doi-asserted-by":"crossref","first-page":"00209","DOI":"10.1183\/23120541.00209-2019","article-title":"Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder","volume":"5","author":"Giri","year":"2019","journal-title":"ERJ Open Res"},{"issue":"8","key":"2021010115051374000_B36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tips.2020.05.003","article-title":"Small molecules restore telomeres in patient stem cells","volume":"41","author":"Brenner","year":"2020","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2021010115051374000_B37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.13692","article-title":"A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita","volume":"1418","author":"Fernandez","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"2021010115051374000_B38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.12688\/f1000research.15542.1","article-title":"An update on the pathogenesis and diagnosis of Diamond-Blackfan anemia","volume":"7","author":"Da Costa","year":"2018","journal-title":"F1000 Res"},{"issue":"2","key":"2021010115051374000_B39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.15701","article-title":"How I manage children with Diamond-Blackfan anaemia","volume":"184","author":"Bartels","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"2021010115051374000_B40","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/bloodadvances.2019001210","article-title":"Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia","volume":"4","author":"Strahm","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2021010115051374000_B41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3324\/haematol.2010.027839","article-title":"Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia","volume":"96","author":"Bizzetto","year":"2011","journal-title":"Haematologica"},{"issue":"4","key":"2021010115051374000_B42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/ejh.13463","article-title":"Hematopoietic cell transplantation for Diamond Blackfan anemia: a report from the Pediatric Group of the Brazilian Bone Marrow Transplantation Society","volume":"105","author":"Darrigo","year":"2020","journal-title":"Eur J Haematol"},{"issue":"16","key":"2021010115051374000_B43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","article-title":"Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"126","author":"Fioredda","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2021010115051374000_B44","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41409-020-0863-z","article-title":"Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) [published correction in Bone Marrow Transplant. 2020;55:1884]","volume":"55","author":"Cesaro","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2021010115051374000_B45","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.bbmt.2020.04.029","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome","volume":"26","author":"Myers","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2021010115051374000_B46","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.bbmt.2013.12.099","article-title":"Allogenic stem cell transplantation in amegacaryocytosis: results of a retrospective study in EBMT centers","volume":"20","author":"Dalle","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2021010115051374000_B47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbmt.2020.02.015","article-title":"Comparison of outcomes of myeloablative allogeneic stem cell transplantation for pediatric patients with bone marrow failure, myelodysplastic syndrome and acute myeloid leukemia with and without germline GATA2 mutations","volume":"26","author":"Hofmann","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2021010115051374000_B48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2021010115051374000_B49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/bloodadvances.2018016501","article-title":"MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia","volume":"2","author":"Germeshausen","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"2021010115051374000_B50","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.bbmt.2019.07.007","article-title":"Outcomes of hematopoietic cell transplantation in patients with germline SAMD9\/SAMD9L mutations","volume":"25","author":"Ahmed","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2020\/1\/107\/1795800\/hem2020000095c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2020\/1\/107\/1795800\/hem2020000095c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T15:05:51Z","timestamp":1609513551000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2020\/1\/107\/474278\/Special-pre-and-posttransplant-considerations-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2020000095","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}